Remote Cognitive Behavioral Therapy for Insomnia

Remote cognitive behavioral therapy for insomnia: A pilot study with a randomized, multilevel baseline design

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1030210575

Enrollment

Registered

2022-01-23

Start date

2022-01-25

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Disorder Insomnia

Interventions

Cognitive Behavioral Therapy for Insomnia (CBT-I) includes 1) sleep hygiene, 2) stimulus control and sleep restriction, 3) titration, 4) daytime activities, and 5) review and relapse prevention. The i

D015928

Cognitive behavioral therapy, Telepsychology, Telepsychological services, CBT-I

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Meeting DSM-5 diagnosis criteria of chronic insomnia. 2. Has insomnia symptoms of at least mild severity or worse on the Insomnia Severity Index (ISI >= 8) 3. 18 years of age or older

Exclusion criteria

Exclusion criteria: 1. engaged in shift work with night shifts 2. has other sleep disorders that are considered to have a significant impact on insomnia 3. has received or is currently receiving structured psychotherapy 4. determined inappropriate by the doctor for other reasons

Design outcomes

Primary

Measure	Time frame
Insomnia Severity Index: ISI	—

Secondary

Measure	Time frame
1. Occurrence of adverse events 2. Adverse effect checklist for CBT-I 3. Objective sleep indices obtained from polysomnography 4. Subjective sleep indices obtained from sleep diary 5. Self-rated depressive symptoms (Patient Health Questionnaire-9: PHQ-9) 6. Self-rated anxiety symptoms (Generalized Anxiety Disorder-7: GAD-7) 7. Self-rated daytime functioning (Sheehan Disability Scale: SDISS, Epworth Sleepiness Scale: ESS) 8. Cognitive functioning (Cognition) 9. Self-rated insomnia pathology scale (Anxiety and Preoccupation about Sleep Questionnaire: APSQ, Dysfunctional Beliefs and Attitudes about Sleep scale-16: DBAS, Ford Insomnia Response to Stress Test: FIRST) 10. Attitudes about electronic-Therapy (electronic-Therapy Attitudes and Process questionnaire: eTAP, electronic-Therapy Attitudes and Process questionnaire-Therapist version: eTAP-T) 11. Working alliance (A Revised Short Version of Working Alliance Inventory: WAI) 12. Physiological indicators during remote CBT-I (eye gaze, facial expression, Galvanic Skin Response: GSR, voice) 13. Interviews for implementation of remote CBT-I 14. Free description on Remote CBT I 15. Treatment received after post-evaluation	—

Measure

Time frame

1. Occurrence of adverse events 2. Adverse effect checklist for CBT-I 3. Objective sleep indices obtained from polysomnography 4. Subjective sleep indices obtained from sleep diary 5. Self-rated depressive symptoms (Patient Health Questionnaire-9: PHQ-9) 6. Self-rated anxiety symptoms (Generalized Anxiety Disorder-7: GAD-7) 7. Self-rated daytime functioning (Sheehan Disability Scale: SDISS, Epworth Sleepiness Scale: ESS) 8. Cognitive functioning (Cognition) 9. Self-rated insomnia pathology scale (Anxiety and Preoccupation about Sleep Questionnaire: APSQ, Dysfunctional Beliefs and Attitudes about Sleep scale-16: DBAS, Ford Insomnia Response to Stress Test: FIRST) 10. Attitudes about electronic-Therapy (electronic-Therapy Attitudes and Process questionnaire: eTAP, electronic-Therapy Attitudes and Process questionnaire-Therapist version: eTAP-T) 11. Working alliance (A Revised Short Version of Working Alliance Inventory: WAI) 12. Physiological indicators during remote CBT-I (eye gaze, facial expression, Galvanic Skin Response: GSR, voice) 13. Interviews for implementation of remote CBT-I 14. Free description on Remote CBT I 15. Treatment received after post-evaluation

—

Contacts

Public ContactShun Nakajima

University of Tsukuba

nakajima.shun.ga@u.tsukuba.ac.jp+81-29-859-1858

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026